Perspective Therapeutics, Inc. — Director's Dealing 2024

Jul 19, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Perspective Therapeutics, Inc. (CATX)
CIK: 0000728387
Period of Report: 2024-07-17

Reporting Person: Austin Mark John (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-07-17	Stock Option (right to buy)	$11.96	A	34500	Acquired	2034-07-17	Common Stock (34500)	Direct

Footnotes

F1: Option vests over four years with 1/48th of the shares subject to such option vesting and becoming exercisable in substantially equal monthly installments on the monthly anniversary after the Grant Date (07/17/2024), subject to a continued service relationship.